NBTY Trims US Retail Profile While Exiting Contract Manufacturing
This article was originally published in The Tan Sheet
The Vitamin World deal jettisons one of NBTY's slower-performing businesses after the firm previously began exiting the low-margin contract manufacturing sector. The acquisition by a Centre Lane Partners unit is the second private equity move in the supplement space in two weeks.
You may also be interested in...
Carlyle's $2.2bn sale of Nature's Bounty's Holland & Barrett business to a Russian investment fund is the latest sign of the private equity sector's continuing interest in the health and wellness space.
Interim CEO Robert Moran says "we found … a badly broken business in need of change" since he took the helm in July. The broken parts include a loyalty program not driving sales; inconsistent and confusing pricing; and point-of-sale checkout failures.
Swander Pace Capital's Swanson Health deal announced Jan. 25 is the firm's second in two months in the supplement industry after acquiring Captek Softgel in December. OTC drug and supplement firms in 2016 could be among the consumer product spaces targeted in likely higher private equity investing.